Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring

<table>Ribavirin plasma concentration at week 4 according to subsequent treatment response. Modified from Maynard et al. [<a href="/journals/ahe/2014/493087/#B8">8</a>].</table>

Advances in Hepatology

fig3

Figure 3

Figure 3: Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring 

Figure 3 | Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring 